Your browser doesn't support javascript.
loading
Expansion of memory Vδ2 T cells following SARS-CoV-2 vaccination revealed by temporal single-cell transcriptomics.
Terzoli, Sara; Marzano, Paolo; Cazzetta, Valentina; Piazza, Rocco; Sandrock, Inga; Ravens, Sarina; Tan, Likai; Prinz, Immo; Balin, Simone; Calvi, Michela; Carletti, Anna; Cancellara, Assunta; Coianiz, Nicolò; Franzese, Sara; Frigo, Alessandro; Voza, Antonio; Calcaterra, Francesca; Di Vito, Clara; Della Bella, Silvia; Mikulak, Joanna; Mavilio, Domenico.
  • Terzoli S; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Marzano P; Department of Biomedical Sciences, Humanitas University, Milan, Pieve Emanuele, Italy.
  • Cazzetta V; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Piazza R; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Sandrock I; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Ravens S; Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
  • Tan L; Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
  • Prinz I; Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
  • Balin S; Institute of Systems Immunology, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Calvi M; Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
  • Carletti A; Institute of Systems Immunology, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Cancellara A; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Coianiz N; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Franzese S; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Frigo A; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Voza A; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Calcaterra F; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
  • Di Vito C; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Della Bella S; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Mikulak J; Laboratory of Clinical and Experimental Immunology, IRCCS Humanitas Research Hospital, Milan, Rozzano, Italy.
  • Mavilio D; Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
NPJ Vaccines ; 9(1): 63, 2024 Mar 20.
Article en En | MEDLINE | ID: mdl-38509155
ABSTRACT
γδ T cells provide rapid cellular immunity against pathogens. Here, we conducted matched single-cell RNA-sequencing and γδ-TCR-sequencing to delineate the molecular changes in γδ T cells during a longitudinal study following mRNA SARS-CoV-2 vaccination. While the first dose of vaccine primes Vδ2 T cells, it is the second administration that significantly boosts their immune response. Specifically, the second vaccination uncovers memory features of Vδ2 T cells, shaped by the induction of AP-1 family transcription factors and characterized by a convergent central memory signature, clonal expansion, and an enhanced effector potential. This temporally distinct effector response of Vδ2 T cells was also confirmed in vitro upon stimulation with SARS-CoV-2 spike-peptides. Indeed, the second challenge triggers a significantly higher production of IFNγ by Vδ2 T cells. Collectively, our findings suggest that mRNA SARS-CoV-2 vaccination might benefit from the establishment of long-lasting central memory Vδ2 T cells to confer protection against SARS-CoV-2 infection.